心血管リスク管理と腹部大動脈動脈瘤の成長における性差:現代のコホート研究からの洞察
Fahad Alkhalfan1, Essa Hariri2, Anu Aggarwal3
1Section of Vascular Medicine, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Heart, Blood, and Kidney Research, Cleveland Clinic Research, Cleveland, OH, USA.
Atherosclerosis
|February 19, 2026
まとめ
腹部大動脈動脈瘤 (AAA) を患っている女性は,心血管疾患のリスク軽減戦略を少なく受ける. アンジオテンシン変換酵素阻害剤/アンジオテンシン受容体阻害剤 (ACEi/ARBs) は,女性におけるAAAの成長を遅らせる可能性があるため,公平な管理のためにさらなる研究が必要である.
科学分野:
- 心血管医学は,心臓血管医学である.
- 血管外科 血管外科
- 医学的な成果 研究研究
背景:
- 腹動脈動脈瘤 (AAA) は男性に多く見られるが,女性では破裂リスクと死亡率が高くなる.
- 既存の研究は,AAAの管理と成果における性差をしばしば無視している.
研究 の 目的:
- AAA患者の心血管リスク軽減戦略における性差を比較する.
- AAAの成長と結果に影響を与える性特有の要因を調査する.
主な方法:
- 2008年患者 (20%女性) のAAA成長率とアウトカムに関する10年間の分析.
- 男性と女性のベースラインの人口統計と薬の処方パターンの比較.
- 逆行選択を用いたAAAの急速な成長 (≥0.5cm/年) と関連した変数の識別,性別別層化.
主要な成果:
- 女性は,高血圧,喫煙率,スタチンとACEi/ARBの使用量が低く示されました.
- 急速な成長,解剖,破裂,修復,または死亡率において有意な性差は見つかりませんでした.
- ACEi/ARBは女性ではAAAの成長が遅くなっていたが,男性ではそうではなかった.
結論:
- AAAの男性と女性に適用される心臓血管リスク軽減戦略には格差があります.
- 特に女性におけるAAAの増加を遅らせるACEi/ARBの潜在的な利点は,さらなる調査を必要としています.
- 標的と公平な心血管リスク管理戦略は,AAA患者にとって極めて重要です.
関連する概念動画
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


